Advances in the management of digoxin toxicity in the older patient

Drugs and Aging

Volumn 10, Issue 1, 1997, Pages 18-33

  Borron, Stephen W ^a   Bismuth, Chantal ^a   Muszynski, Jerzy ^a  

^a HÔPITAL FERNAND WIDAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CARDIAC GLYCOSIDE; DIGOXIN; IMMUNOGLOBULIN F(AB) FRAGMENT;

AGING; ATRIOVENTRICULAR BLOCK; CARDIOVASCULAR DISEASE; CARDIOVERSION; CONGESTIVE HEART FAILURE; DRUG INTOXICATION; HEART PACING; HUMAN; HYPERKALEMIA; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEX DIFFERENCE;

EID: 0031018489     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199710010-00003     Document Type: Review

References (77)

1. Litovitz TL, Felberg L, Soloway RA, et al. 1994 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1995; 13 (5): 551-97
2. Passmore AP, Johnston GD. Digoxin toxicity in the aged: characterising and avoiding the problem. Drugs Aging 1991; 1 (5): 364-79
3. Haïat R. Digitaliques: l'ère de la digoxine. Paris: Editions Frison-Roche, 1995
4. Cusack B, Kelly J, O'Malley K, et al. Digoxin in the elderly: pharmacokinetic consequences of old age. Clin Pharmacol Ther 1979; 25(6): 772-6
5. Smith TW. Pharmacokinetics, bioavailability and serum levels of cardiac glycosides. J Am Coll Cardiol 1985; 5 Suppl. A: 43-50
6. Kelly RA, Smith TW. Pharmacological treatment of heart failure. In: Hardman JG, Limbird LE, Molinoff PB, et al., editors. Goodman & Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996: 809-38
7. Hoffman BF, Bigger Jr JT. Digitalis and allied cardiac glycosides. In: Gilman AG, Goodman LS, Rall TW, et al., editors. Goodman & Gilman's the pharmacological basis of therapeutics. 7th ed. New York: MacMillan, 1985: 716-47
8. Giudicelli JF, Tillement JP. Pharmacologie et métabolisme des glucosides cardiotoniques. Rev Prat 1976; 49: 3413-9
9. Ewy G, Kapadia G, Yao L, et al. Digoxin metabolism in the elderly. Circulation 1969; 39: 449-53
10. Leikin JB, Paloucek FP. Poisoning and toxicology handbook. 2nd ed. Cleveland (OH): Lexi-Comp, 1995
11. Ford A, Smith LC, Baltch AL, et al. Clarithromycin-induced digoxin toxicity in a patient with AIDS. Clin Infect Dis 1995; 21: 1051-2
12. Midoneck SR, Etingin OR. Clarithromycin-related toxic effects of digoxin [letter]. N Engl J Med 1995; 333 (22): 1505
13. Alderman CP, Jersmann HPA. Digoxin-itraconazole interaction [letter]. Med J Aust 1993; 159 (6): 838-9
14. McClure AF, Alderman CP, Hayball PJ. Itraconazole does not interfere with fluorescence polarization immunoassay of serum digoxin [letter]. Ann Pharmacother 1995; 29: 938
15. Rex J. Itraconazole-digoxin interaction [letter]. Ann Intern Med 1992; 116: 525
16. Sachs MK, Blanchard LM, Green PJ. Interaction of itraconazole and digoxin. Clin Infect Dis 1993; 16: 400-3
17. McClean KL, Sheehan GJ. Interaction between itraconazole and digoxin [letter]. Clin Infect Dis 1994; 18: 259-60
18. Bigot M-C, Bebruyne D, Bonnefoy L, et al. Serum digoxin levels related to plasma propafenone levels during concomitant treatment. J Clin Pharmacol 1991; 31: 521-6
19. Nolan PE, Marcus FI, Erstad BL, et al. Effects of coadministration of propafenone on the pharmacokinetics of digoxin in healthy volunteer subjects. J Clin Pharmacol 1989; 29: 46-52
20. Ujhelyi MR. Spotlight article: quinidine enhances digitalis toxicity at therapeutic serum digoxin levels. Heart Lung 1993; 22 (6): 560-2
21. Beller GA, Smith TW, Abelmann WH, et al. Digitalis intoxication: a prospective clinical study with serum level concentrations. N Engl J Med 1971; 284 (18): 989-97
22. Ordog GJ, Benaron S, Bhasin V, et al. Serum digoxin levels and mortality in 5,100 patients. Ann Emerg Med 1987; 16 (1): 32-9
23. Lely AH, Enter CHJV. Large-scale digoxin intoxication. BMJ 1970; 3: 737-40
24. Mason DT, DeMaria AN, Amsterdam EA. et al. Antiarrhythmic agents: II. Therapeutic considerations. Drugs 1973; 5 (4): 292-317
25. Butler Jr VP, Odel JG, Rath E, et al. Digitalis-induced visual disturbances with therapeutic serum digitalis concentrations. Ann Intern Med 1995; 123 (9): 676-80
26. Brezis M, Michaeli J, Hamburger R. Nightmares from digoxin [letter]. Ann Intern Med 1980; 93 (4): 639-40
27. Cordeiro MF, Arnold KG. Digoxin toxicity presenting as dysphagia and dysphonia [letter]. BMJ 1991; 302 (6783): 1025
28. Closson RG. Visual hallucinations as the earliest symptom of digoxin intoxication. Arch Neurol 1983; 40 (6): 386
29. Taboulet P. Conduite à tenir et place des anticorps spécifiques devant une intoxication digitalique. In: Baud F, editor. Réanimation des intoxications aiguës. Paris: Masson, 1995: 150-7
30. Gaultier M, Bismuth C. L'intoxication digitalique aiguë. Rev Prat 1978; 28 (57): 4565-79
31. Shear MK, Sacks MH. Digitalis delirium: report of two cases. Am J Psychiatry 1978; 135 (1): 109-10
32. Eisendrath SJ, Sweeney MA. Toxic neuropsychiatric effects of digoxin at therapeutic serum concentrations. Am J Psychiatry 1987; 144: 506-7
33. Varriale P, Mossavi A. Rapid reversal of digitalis delirium using digoxin immune Fab therapy. Clin Cardiol 1995; 18: 351-2
34. Volpe BT, Soave R. Formed visual hallucinations as digitalis toxicity. Ann Intern Med 1979; 91 (6): 865-6
35. Singh RB, Singh VP, Somani PN. Psychosis: a rare manifestation of digoxin intoxication. J Indian Med Assoc 1977; 69 (3): 62-3
36. Mahdyoon H, Battilana G, Rosman H, et al. The evolving pattern of digoxin intoxication: observations at a large urban hospital from 1980 to 1988. Am Heart J 1990; 120: 1189-94
37. Granier P, Arsac P. Spasme artériel diffus au cours d'une intoxication digitalique. Rev Med Interne 1983; 4: 361-2
38. Patard O, Desnons M, Leroy G, et al. Nécrose hémorragique du tube digestif au cours d'une intoxication digitalique massive. Presse Med 1981; 10: 1489-91
39. Kelly RA, Smith TW. Recognition and management of digitalis toxicity. Am J Cardiol 1992; 69: 108G-119G
40. Dally S, Alperovitch A, Lagier G, et al. Facteurs pronostiques de l'intoxication digitalique aiguë. Presse Med 1981; 10 (27): 2257-60
41. Bismuth C, Gaultier M, Conso F, et al. Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications. Clin Toxicol 1973; 6 (2): 153-62
42. Taboulet P, Baud FJ, Bismuth C. Clinical features and management of digitalis poisoning: rationale for immunotherapy. Clin Toxicol 1993; 31 (2): 247-60
43. Hickey AR, Wenger TL, Carpenter VP, et al. Digoxin immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study. J Am Coll Cardiol 1991; 17 (3): 590-8
44. Ellenhorn MJ, Barceloux DG. Medical toxicology: diagnosis and treatment of human poisoning. New York: Elsevier, 1988
45. Lewis RP, Digitalis. In: Leier CV, editor. Cardiotonic drugs: a clinical survey. New York: Marcel Dekker, 1987: 85-150
46. Gaultier M, Welti JJ, Bismuth C, et al. Intoxication digitalique grave: facteurs pronostiques, intérêt et limites de l'entrainement électrosystolique (à propos de 133 cas). Ann Med Interne (Paris) 1976; 127 (10): 761-6
47. Merigian KS, Woodard M, Hedges JR, et al. Prospective evaluation of gastric emptying in the self-poisoned patient. Am J Emerg Med 1990; 8: 479-83
48. Kulig K, Bar-Or D, Cantrill SV, et al. Management of acutely poisoned patients without gastric emptying. Ann Emerg Med 1985; 14 (6): 562-7
49. Tenenbein M. Inefficacy of gastric emptying procedures. J Emerg Med 1985; 3: 133-6
50. Pond SM, Lewis-Driver DJ, Williams GM, et al. Gastric emptying in acute overdose: a prospective randomised controlled trial. Med J Aust 1995; 163: 345-9
51. Lheureux P, Askenasi R. Prévention de l'absorption digestive des toxiques: une réévaluation critique première partie: l'evacuation du contenu gastrique. Reanim Urg 1992: 1 (5): 751-9
52. Raphael JC. Déséquilibres hydroélectrolytiques. In: Goulon M, Barois A, Bourdarias JP, editors. Les urgences: reconnaître, comprendre, traiter. 2nd ed. Quebec: Édisem Inc., 1990: 19-88
53. Kinlay S, Buckley NA. Magnesium sulfate in the treatment of ventricular arrhythmias due to digoxin toxicity. Clin Toxicol 1995; 33 (1): 55-9
54. Bismuth C, Motte G, Conso F, et al. Acute digitoxin intoxication treated by intracardiac pacemaker: experience in sixty-eight patients. Clin Toxicol 1977; 10 (4): 443-56
55. Smith TW, Haher E, Yeatman L, et al. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-spceific antibodies. N Engl J Med 1976; 294: 797-800
56. Murphy DJ, Bremner WF, Haber E, et al. Massive digoxin poisoning treated with Fab fragments of digoxin-specific antibodies. Pediatrics 1982; 70 (3): 472-3
57. Aeberhard P, Butler VP, Smith TW, et al. Le traitement d'une intoxication digitalique massive (20 mg de digitoxine) par les anticorps anti-digoxine fractionnés (Fab). Arch Mal Coeur Vaiss 1980; 73 (12): 1471-8
58. Lignian H, Vincent JL, Hallemans R. Treatment of severe digitoxin intoxication by digoxin-specific Fab antibody fragments. Acta Cardiol 1984; 39 (4): 301-5
59. Domart Y, Bismuth C, Scherrmann JM, et al. Intoxication par Ia digitoxine: réversibilité d'une fibrillation ventriculaire par fragments Fab d'anticorps antidinoxine. Nouv Presse Med 1982; 11 (52): 3827-30
60. Amman EM, Wenger TL, Butler Jr VP, et al. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: final report of a multicenter study. Circulation 1990; 81: 1744-52
61. Smolarz A, Roesch E, Lenz E, et al. Digoxin specific antibody (Fab) fragments in 34 cases of severe digitalis intoxication. Clin Toxicol 1985; 23 (4-6): 327-40
62. Curd J, Smith TW, Jaton JC, et al. The isolation of digoxin-specific antibody and its use in reversing the effects of digoxin. Proc Natl Acad Sci U S A 1971; 68 (10): 2401-6
63. Ujhelyi MR, Robert S. Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity. Clin Pharmacokinet 1995; 28 (6): 483-93
64. Baud FJ, Borron SW, Bismuth C. Modifying toxicokinetics with antidotes. Toxicol Lett 1995; 82/83: 785-93
65. Ujhelyi MR, Robert S, Cummings DM, et al. Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxin. Ann Intern Med 1993; 119: 273-7
66. Wenger TL, Butler Jr VP, Haber E, et al. Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments. J Am Coll Cardiol 1985; 5 (5): 118A-23A
67. Smith TW. Review of clinical experience with digoxin immune Fab (ovine). Am J Emerg Med 1991; 9 (2 Suppl. 1): 1-6
68. Ujhelyi MR, Cummings DM, Green P, et al. Effect of digoxin Fab antibodies on five digoxin assays. Ther Drug Monit 1990; 12 (3): 288-92
69. Ujhelyi MR, Green PJ, Cummings DM, et al Determination of free serum digoxin concentrations in digoxin toxic patients after administration of digoxin Fab antibodies. Ther Drug Monit 1992; 14 (2): 147-54
70. Hursting MJ, Raisys VA, Opheim KE, et al. Determination of free digoxin concentrations in serum for monitoring Fab treatment of digoxin overdose. Clin Chem 1987; 33 (9): 1652-5
71. Robert S, Ujhelyi M, Zarowitz BJ. Reinstitution of digoxin after digoxin Fab antibody therapy in a hemodialyzed patient. Crit Care Med 1993; 21 (10): 1585-7
72. Bourhis F, Riard P, Danel V, et al. Intoxication digitalique avec ischémie colique grave: évolution favorable après traitement par anticorps spécifiques. Gastroenterol Clin Biol 1990; 14: 95-106
73. Hess T, Reisen W, Scholtysik G, et al. Digitoxin intoxication with severe thrombocytopenia: reversal by digoxin-specific antibodies. Eur J Clin Invest 1983; 13 (2): 159-63
74. Domart Y, Bismuth C, Pontal PG, et al. Réversibilité d'une intoxication grave par digitoxine sous anticorps anti-digoxine. Ann Med Interne (Paris) 1983; 134 (6): 555-8
75. Ochs HR, Smith TW. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments. J Clin Invest 1977; 60: 1303-13
76. Taboulet P, Baud FJ, Bismuth C, et al. Acute digitalis intoxication: is pacing still appropriate? Clin Toxicol 1993; 31 (2): 261-74
77. Schaumann W, Kaufmann B, Neubert P, et al. Kinetics of the Fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication. Eur J Clin Pharmacol 1986; 30: 527-33